Cannabis, the mind and society: the hash realities (Q34699888)

4 August 2017

1 reference

title

Cannabis, the mind and society: the hash realities (English)

1 reference

4 August 2017

Robin M Murray

1

0 references

author name string

Paul D Morrison

series ordinal

2

1 reference

4 August 2017

Cécile Henquet

series ordinal

3

1 reference

4 August 2017

Marta Di Forti

series ordinal

4

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 November 2007

1 reference

Nature Reviews Neuroscience

4 August 2017

published in

1 reference

4 August 2017

volume

8

1 reference

4 August 2017

issue

11

1 reference

4 August 2017

page(s)

885-895

1 reference

Role of endogenous cannabinoids in synaptic signaling

4 August 2017

cites work

1 reference

Psychotic reactions following cannabis use in East Indians.

21 January 2018

1 reference

Tracking difficulties and paranoid ideation during hashish and alcohol intoxication

21 January 2018

1 reference

Differential effects of THC- or CBD-rich cannabis extracts on working memory in rats

21 January 2018

1 reference

Cannabis use and psychiatric and cogitive disorders: the chicken or the egg?

21 January 2018

1 reference

Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil

21 January 2018

1 reference

The endocannabinoid system as an emerging target of pharmacotherapy

21 January 2018

1 reference

31 March 2020

Cannabis and the brain

1 reference

Cannabinoid receptors as therapeutic targets.

31 March 2020

1 reference

The molecular logic of endocannabinoid signalling

31 March 2020

1 reference

The endocannabinoid system and its therapeutic exploitation

31 March 2020

1 reference

The neurobiology and evolution of cannabinoid signalling

31 March 2020

1 reference

A historical overview of chemical research on cannabinoids

31 March 2020

1 reference

Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716.

31 March 2020

1 reference

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

31 March 2020

1 reference

Neuronal localization of cannabinoid receptors in the basal ganglia of the rat.

31 March 2020

1 reference

Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB.

31 March 2020

1 reference

Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis

31 March 2020

1 reference

Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia

31 March 2020

1 reference

Control of pain initiation by endogenous cannabinoids.

31 March 2020

1 reference

Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons.

31 March 2020

1 reference

An endocannabinoid mechanism for stress-induced analgesia.

31 March 2020

1 reference

Molecular characterization of a peripheral receptor for cannabinoids

31 March 2020

1 reference

Identification and functional characterization of brainstem cannabinoid CB2 receptors

31 March 2020

1 reference

Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain

31 March 2020

1 reference

Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain

31 March 2020

1 reference

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

31 March 2020

1 reference

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

31 March 2020

1 reference

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

31 March 2020

1 reference

Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses

31 March 2020

1 reference

Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor.

31 March 2020

1 reference

Molecular composition of the endocannabinoid system at glutamatergic synapses.

31 March 2020

1 reference

The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum

31 March 2020

1 reference

Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum.

31 March 2020

1 reference

Endocannabinoids and their implications for epilepsy

31 March 2020

1 reference

Is heterosynaptic modulation essential for stabilizing Hebbian plasticity and memory?

31 March 2020

1 reference

Endocannabinoid-mediated synaptic plasticity in the CNS.

31 March 2020

1 reference

Postsynaptic endocannabinoid release is critical to long-term depression in the striatum

31 March 2020

1 reference

Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens

31 March 2020

1 reference

Cerebellar depolarization-induced suppression of inhibition is mediated by endogenous cannabinoids.

31 March 2020

1 reference

Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models

31 March 2020

1 reference

Endogenous cannabinoid signaling through the CB1 receptor is essential for cerebellum-dependent discrete motor learning

31 March 2020

1 reference

The endogenous cannabinoid system controls extinction of aversive memories

31 March 2020

1 reference

Persistent synaptic activity produces long-lasting enhancement of endocannabinoid modulation and alters long-term synaptic plasticity

31 March 2020

1 reference

Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability

31 March 2020

1 reference

Endocannabinoid-mediated metaplasticity in the hippocampus

31 March 2020

1 reference

Endocannabinoids facilitate the induction of LTP in the hippocampus

31 March 2020

1 reference

The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus

31 March 2020

1 reference

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

31 March 2020

1 reference

The endocannabinoid system controls key epileptogenic circuits in the hippocampus

31 March 2020

1 reference

Cannabinoids reveal importance of spike timing coordination in hippocampal function

31 March 2020

1 reference

Cannabinoids, hippocampal function and memory

31 March 2020

1 reference

Testing the self-medication hypothesis of depression and aggression in cannabis-dependent subjects

31 March 2020

1 reference

Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study

31 March 2020

1 reference

A clinical and metabolic study of acute intoxication with Cannabis sativa and its role in the model psychoses

31 March 2020

1 reference

Effects of (--)delta-9-trans-tetrahydrocannabinol in man

31 March 2020

1 reference

The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

31 March 2020

1 reference

Different effects of nabilone and cannabidiol on binocular depth inversion in Man.

31 March 2020

1 reference

Low doses of delta-9 tetrahydrocannabinol (THC) have divergent effects on short-term spatial memory in young, healthy adults

31 March 2020

1 reference

Cannabinoid ligands and their effects on learning and performance in rhesus monkeys.

31 March 2020

1 reference

Neurocognitive consequences of marihuana--a comparison with pre-drug performance.

31 March 2020

1 reference

Neural substrates of faulty decision-making in abstinent marijuana users.

31 March 2020

1 reference

Specific attentional dysfunction in adults following early start of cannabis use.

31 March 2020

1 reference

Early-onset cannabis use and cognitive deficits: what is the nature of the association?

31 March 2020

1 reference

Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation

31 March 2020

1 reference

Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats

31 March 2020

1 reference

Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats

31 March 2020

1 reference

Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey

31 March 2020

1 reference

Cannabis and psychosis. Is there epidemiological evidence for an association?

31 March 2020

1 reference

Cannabis and psychotic illness

31 March 2020

1 reference

Cannabis abuse and the course of recent-onset schizophrenic disorders

31 March 2020

1 reference

Cannabis use and outcome of recent onset psychosis

31 March 2020

1 reference

CANNABIS AND SCHIZOPHRENIA A Longitudinal Study of Swedish Conscripts

31 March 2020

1 reference

Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study

31 March 2020

1 reference

Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study

31 March 2020

1 reference

Causal association between cannabis and psychosis: examination of the evidence

31 March 2020

1 reference

The environment and schizophrenia: the role of cannabis use.

31 March 2020

1 reference

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review

31 March 2020

1 reference

Cannabis use and psychosis: a longitudinal population-based study.

31 March 2020

1 reference

Cannabis dependence and psychotic symptoms in young people

31 March 2020

1 reference

Tests of causal linkages between cannabis use and psychotic symptoms

31 March 2020

1 reference

31 March 2020

1 reference

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

31 March 2020

1 reference

From dopamine to salience to psychosis--linking biology, pharmacology and phenomenology of psychosis.

31 March 2020

1 reference

Hallucinatory experiences and onset of psychotic disorder: evidence that the risk is mediated by delusion formation.

31 March 2020

1 reference

Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats.

31 March 2020

1 reference

Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area.

31 March 2020

1 reference

Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra

31 March 2020

1 reference

Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism

31 March 2020

1 reference

Cannabis induced dopamine release: an in-vivo SPECT study

31 March 2020

1 reference

Two cases of "cannabis acute psychosis" following the administration of oral cannabis

31 March 2020

1 reference

Validity and reliability of the CAPE: a self-report instrument for the measurement of psychotic experiences in the general population.

31 March 2020

1 reference

Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people

31 March 2020

1 reference

Intermediate phenotypes and genetic mechanisms of psychiatric disorders

31 March 2020

1 reference

Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction

31 March 2020

1 reference

An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition

31 March 2020

1 reference

Prevalence and correlates of cannabis use in developed and developing countries

31 March 2020

1 reference

Measuring the reinforcing strength of abused drugs

31 March 2020

1 reference

What we have learned about addiction from animal models of drug self-administration

31 March 2020

1 reference

Delta9-tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats

31 March 2020

1 reference

Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys

31 March 2020

1 reference

Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys.

31 March 2020

1 reference

Endocannabinoid signaling system and brain reward: emphasis on dopamine

31 March 2020

1 reference

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

31 March 2020

1 reference

Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction.

31 March 2020

1 reference

Variation in youthful risks of progression from alcohol and tobacco to marijuana and to hard drugs across generations

31 March 2020

1 reference

Does marijuana use cause the use of other drugs?

31 March 2020

1 reference

Reassessing the marijuana gateway effect

31 March 2020

1 reference

Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis

31 March 2020

1 reference

Escalation of drug use in early-onset cannabis users vs co-twin controls

31 March 2020

1 reference

Perinatal exposure to delta(9)-tetrahydrocannabinol alters heroin-induced place conditioning and fos-immunoreactivity

31 March 2020

1 reference

Exposure to delta-9-tetrahydrocannabinol (THC) increases subsequent heroin taking but not heroin's reinforcing efficacy: a self-administration study in rats

31 March 2020

1 reference

Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats

31 March 2020

1 reference

Prenatal cannabis exposure increases heroin seeking with allostatic changes in limbic enkephalin systems in adulthood

31 March 2020

1 reference

Reverse gateways? Frequent cannabis use as a predictor of tobacco initiation and nicotine dependence

31 March 2020

1 reference

'You can't go without a fag...you need it for your hash'--a qualitative exploration of smoking, cannabis and young people

31 March 2020

1 reference

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial

31 March 2020

1 reference

Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis

31 March 2020

1 reference

Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis

31 March 2020

1 reference

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

31 March 2020

1 reference

First cannabis use: does onset shift to younger ages? Findings from 1988 to 2003 from the Dutch National School Survey on Substance Use.

31 March 2020

1 reference

Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales

31 March 2020

1 reference

Incidence of schizophrenia in south-east London between 1965 and 1997

31 March 2020

1 reference

Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999.

31 March 2020

1 reference

Psychotic experiences in the general population: a twenty-year prospective community study

31 March 2020

1 reference

Evaluating alternative cannabis regimes

31 March 2020

1 reference

Alcohol dependence: provisional description of a clinical syndrome

31 March 2020

1 reference

2-Arachidonoylglycerol (2-AG) membrane transport: history and outlook

31 March 2020

1 reference

Brain monoglyceride lipase participating in endocannabinoid inactivation

31 March 2020

1 reference

Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus

31 March 2020

1 reference

Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the hippocampus

31 March 2020

1 reference

Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers

31 March 2020

1 reference

Clinical characteristics of adolescents later hospitalized for schizophrenia

31 March 2020

1 reference

Cannabis use predicts future psychotic symptoms, and vice versa

31 March 2020

1 reference

Self-reported psychotic symptoms in the general population

31 March 2020

1 reference

A Total Synthesis of dl-Δ1-Tetrahydrocannabinol, the Active Constituent of Hashish1

31 March 2020

1 reference

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

31 March 2020

1 reference

Cannabinoids control spasticity and tremor in a multiple sclerosis model

31 March 2020

1 reference

Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors

31 March 2020

1 reference

Neocortical LTD via coincident activation of presynaptic NMDA and cannabinoid receptors

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRN2253

1 reference

Dimensions Publication ID

4 August 2017

1036320365

0 references

1 reference